{"id":"https://openalex.org/W2319123740","doi":"https://doi.org/10.1055/s-0028-1088699","title":"Fulvestrant, eine kostennutzwerte Option in der palliativen Situation. \u2013 Ergebnisse des German Faslodex\u00ae health economic sequencing model","display_name":"Fulvestrant, eine kostennutzwerte Option in der palliativen Situation. \u2013 Ergebnisse des German Faslodex\u00ae health economic sequencing model","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2319123740","doi":"https://doi.org/10.1055/s-0028-1088699","mag":"2319123740"},"language":"de","primary_location":{"id":"doi:10.1055/s-0028-1088699","doi":"https://doi.org/10.1055/s-0028-1088699","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0028-1088699","pdf_url":null,"source":{"id":"https://openalex.org/S146294059","display_name":"Geburtshilfe und Frauenheilkunde","issn_l":"0016-5751","issn":["0016-5751","1438-8804","2199-6989"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Geburtshilfe und Frauenheilkunde","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103497574","display_name":"MP Lux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"MP Lux","raw_affiliation_strings":["Frauenklinik des Universit\u00e4tsklinikums Erlangen, Erlangen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frauenklinik des Universit\u00e4tsklinikums Erlangen, Erlangen","institution_ids":["https://openalex.org/I4210088053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027231412","display_name":"Nadia Harbeck","orcid":"https://orcid.org/0000-0002-9744-7372","observed_orcids":["https://orcid.org/0000-0002-9744-7372"]},"institutions":[{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"N Harbeck","raw_affiliation_strings":["Frauenklinik am Klinikum rechts der Isar der TU M\u00fcnchen, M\u00fcnchen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frauenklinik am Klinikum rechts der Isar der TU M\u00fcnchen, M\u00fcnchen","institution_ids":["https://openalex.org/I2802619606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066998006","display_name":"Michael Hartmann","orcid":"https://orcid.org/0000-0002-6777-4540","observed_orcids":["https://orcid.org/0000-0002-6777-4540"]},"institutions":[{"id":"https://openalex.org/I4210134900","display_name":"Jena University Hospital","ror":"https://ror.org/035rzkx15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210134900"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M Hartmann","raw_affiliation_strings":["Apotheke des Universit\u00e4tsklinikums Jena, Jena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Apotheke des Universit\u00e4tsklinikums Jena, Jena","institution_ids":["https://openalex.org/I4210134900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029558979","display_name":"G. Raab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156288","display_name":"Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe","ror":"https://ror.org/02794jc95","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I4387156288","https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"G Raab","raw_affiliation_strings":["Praxis f\u00fcr Frauenheilkunde und Geburtshilfe, M\u00fcnchen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Praxis f\u00fcr Frauenheilkunde und Geburtshilfe, M\u00fcnchen","institution_ids":["https://openalex.org/I4387156288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086631097","display_name":"Angelika Schneeweiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A Schneeweiss","raw_affiliation_strings":["Universit\u00e4t Heidelberg, Heidelberg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4t Heidelberg, Heidelberg","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110906434","display_name":"K. Possinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Possinger","raw_affiliation_strings":["Med. Univ. u. Poliklinik II Charit\u00e9, Berlin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Med. Univ. u. Poliklinik II Charit\u00e9, Berlin","institution_ids":["https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"68","issue":"S 01","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8190000057220459},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.6660000085830688},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6370000243186951},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8180000185966492},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8489999771118164},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.671999990940094},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.703000009059906},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4090000092983246},{"id":"https://openalex.org/keywords/chemotherapy-comparison","display_name":"chemotherapy comparison","score":0.32600000500679016},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.6850000023841858},{"id":"https://openalex.org/keywords/supportive-care-costs","display_name":"supportive care costs","score":0.6809999942779541},{"id":"https://openalex.org/keywords/diagnostic-costs","display_name":"diagnostic costs","score":0.38999998569488525},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9055727124214172},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6168258190155029},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4613044857978821},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21382251381874084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19127899408340454},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.14855659008026123},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.14496761560440063}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-0028-1088699","doi":"https://doi.org/10.1055/s-0028-1088699","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0028-1088699","pdf_url":null,"source":{"id":"https://openalex.org/S146294059","display_name":"Geburtshilfe und Frauenheilkunde","issn_l":"0016-5751","issn":["0016-5751","1438-8804","2199-6989"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Geburtshilfe und Frauenheilkunde","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2090971609","https://openalex.org/W2139357458","https://openalex.org/W2408920279","https://openalex.org/W2134263978","https://openalex.org/W2941194391","https://openalex.org/W1987489604","https://openalex.org/W2995047340","https://openalex.org/W2620884356","https://openalex.org/W2165026143","https://openalex.org/W1975078828"],"abstract_inverted_index":{"Hintergr\u00fcnde:":[0],"Fulvestrant":[1,26,42,50,97,176,183,211],"stellt":[2],"eine":[3,39],"zus\u00e4tzliche,":[4],"nebenwirkungsarme":[5],"und":[6,32,72,89,109,205],"effektive":[7],"Therapieoption":[8],"von":[9,25,28,70,106,127,175,188,202],"postmenopausalen":[10],"Patientinnen":[11,114],"mit":[12,41,46,124,147,190],"einem":[13,104,191,195],"hormonrezeptorpositiven":[14,192],"fortgeschrittenen":[15],"Mammakarzinom":[16,193],"dar.":[17],"Mittels":[18,34],"eines":[19,35],"gesundheits\u00f6konomischen":[20],"Sequenzmodels":[21],"wurde":[22,38,123,167],"der":[23,44,99,151,161,185,203,208],"Kosten-Nutzwert":[24],"anhand":[27],"QALYS":[29],"berechnet.":[30,95,157],"Material":[31],"Methoden:":[33],"Kalkulationsmodells":[36],"(Markov)":[37],"Kohorte":[40,48,146],"in":[43,98,163,184],"Therapiesequenz":[45],"einer":[47,125],"ohne":[49],"verglichen":[51],"(Zeithorizont":[52],"10":[53],"Jahre;":[54],"Diskontierungsrate":[55],"3%).":[56],"Es":[57,81],"wurden":[58,82,153],"Kosten":[59],"f\u00fcr":[60,76,83,144,172],"Medikamente,":[61],"supportive":[62],"Ma\u00dfnahmen,":[63],"\u00dcberwachung":[64],"unter":[65],"Therapie,":[66],"Diagnostik,":[67],"Progression,":[68],"Therapie":[69,187],"AEs":[71],"SAEs":[73],"als":[74],"auch":[75],"die":[77,90,145],"terminale":[78],"Phase":[79],"ermittelt.":[80],"beide":[84],"Kohorten":[85],"Kosten,":[86],"\u00dcberleben,":[87],"QALYs":[88,111,118],"incremental":[91],"cost-effectiveness":[92],"ratio":[93],"(ICER)":[94],"Ergebnisse:":[96],"2nd":[100],"line":[101],"f\u00fchrte":[102],"zu":[103,194],"Zugewinn":[105],"69":[107],"Lebensjahren":[108],"21":[110],"auf":[112],"1.000":[113,154],"(1,15":[115],"versus":[116,136],"1,13":[117],"pro":[119,130],"Patientin).":[120],"Der":[121,198],"Benefit":[122,199],"Kostenersparnis":[126],"564":[128],"\u20ac":[129,135],"Patientin":[131],"erreicht":[132],"(Gesamtkosten":[133],"13.356":[134],"13.920":[137],"\u20ac).":[138],"Die":[139],"ICER":[140],"demonstrierte":[141],"einen":[142],"Vorteil":[143],"Fulvestrant.":[148],"Im":[149],"Rahmen":[150],"Sensitivit\u00e4tsanalyse":[152],"zuf\u00e4llige":[155],"Szenarien":[156],"Auch":[158],"bei":[159],"\u00c4nderung":[160],"Optionen":[162],"den":[164,173],"unterschiedlichen":[165],"Therapielinien":[166],"ein":[168],"konstanter":[169],"positiver":[170],"Kostennutzwert":[171],"Einsatz":[174],"nachgewiesen.":[177],"Zusammenfassung:":[178],"Das":[179],"Kalkulationsmodell":[180],"zeigt,":[181],"dass":[182],"palliativen":[186],"Frauen":[189],"Kostennutzwertgewinn":[196],"f\u00fchrt.":[197],"bleibt":[200],"unabh\u00e4ngig":[201],"Wahl":[204],"dem":[206],"Modus":[207],"Chemotherapeutika":[209],"bestehen.":[210],"-":[212,214],"Kosten-Nutzen-Analyse":[213],"QALY":[215]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}